Walleye Capital’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-36,446
Closed -$674 2472
2021
Q3
$674 Buy
+36,446
New +$734K 0.02% 650

Other funds holding OCDX

Walleye Capital's OCDX Position: Q4 2021 in Review

Walleye Capital sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q4 2021, closing a stake of 36,446 shares — an estimated $674 sold.

Walleye Capital first reported a position in OCDX in Q3 2021 and held it in 1 quarter. The position peaked at $674 in Q3 2021. 162 funds tracked by Wall St. Rank hold OCDX as of Q4 2021.

  • Walleye Capital reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Walleye Capital sold 36,446 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q4 2021, an estimated $674.
  • Walleye Capital first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 1 quarter.
  • Walleye Capital's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $674 in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q4 2021.

Based on Walleye Capital's 13F filing for Q4 2021, filed 3 Mar 2022.